Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 18,943 | 0 |
| Gross Profit | N/A | N/A | N/A | 18,943 | 0 |
| Operating Expenses | 34,347 | 18,375 | 16,604 | 17,571 | 29,173 |
| Operating Income | -34,347 | -18,375 | -16,604 | 1,372 | -29,173 |
| Other Income | 141 | 116 | 165 | 47 | 67 |
| Pre-tax Income | -34,206 | -18,259 | -16,439 | 1,419 | -29,106 |
| Net Income Continuous | -34,206 | -18,259 | -16,439 | 1,419 | -29,106 |
| Minority Interests | -1,692 | -909 | -803 | 1,489 | -760 |
| Net Income | $-32,514 | $-17,350 | $-15,636 | $-70 | $-28,346 |
| EPS Basic Total Ops | -0.76 | -0.40 | -0.36 | 0.00 | -1.39 |
| EPS Basic Continuous Ops | -0.80 | -0.42 | -0.38 | 0.03 | -1.43 |
| EPS Diluted Total Ops | -0.76 | -0.40 | -0.36 | 0.00 | -1.39 |
| EPS Diluted Continuous Ops | -0.80 | -0.42 | -0.38 | 0.03 | -1.43 |
| EBITDA(a) | $-34,335 | $-18,362 | $-16,591 | $1,387 | $-29,158 |